José Martínez-González Selected Research

Atherosclerosis

10/2021	NR4A3: A Key Nuclear Receptor in Vascular Biology, Cardiovascular Remodeling, and Beyond.
10/2020	Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis †.
1/2019	Oxidized Low-Density Lipoprotein Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease.
1/2019	Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1.
5/2018	Mechanisms of vascular aging: What can we learn from Hutchinson-Gilford progeria syndrome?
1/2018	MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis.
11/2016	Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis.
1/2016	Nestin(+) cells direct inflammatory cell migration in atherosclerosis.
12/2013	A major role for RCAN1 in atherosclerosis progression.
11/2011	Deficient p27 phosphorylation at serine 10 increases macrophage foam cell formation and aggravates atherosclerosis through a proliferation-independent mechanism.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Martínez-González Research Topics

Disease

18	Inflammation (Inflammations) 07/2022 - 01/2007
18	Atherosclerosis 10/2021 - 01/2003
8	Atherosclerotic Plaque (Atheroma) 10/2020 - 09/2002
8	Thrombosis (Thrombus) 10/2020 - 03/2003
6	Abdominal Aortic Aneurysm 03/2021 - 12/2013
5	Vascular Remodeling 01/2021 - 03/2011
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 07/2008
5	Hypoxia (Hypoxemia) 09/2016 - 11/2009
4	Rupture 01/2021 - 01/2008
4	Fibrosis (Cirrhosis) 01/2020 - 01/2013
4	Stroke (Strokes) 05/2018 - 01/2007
4	Myocardial Infarction 05/2018 - 03/2006
4	Heart Failure 01/2017 - 01/2013
3	Aneurysm (Aneurysms) 04/2021 - 01/2016
3	Cardiomegaly (Heart Hypertrophy) 01/2020 - 03/2016
3	Obesity 11/2019 - 06/2015
3	Body Weight (Weight, Body) 11/2019 - 06/2015
3	Heart Diseases (Heart Disease) 09/2015 - 11/2011
3	Neoplasms (Cancer) 05/2010 - 02/2008
2	Neointima 05/2013 - 05/2013
2	Venous Thromboembolism 05/2010 - 07/2008
2	Necrosis 08/2009 - 01/2008
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 02/2008 - 06/2007
2	Wounds and Injuries (Trauma) 02/2006 - 01/2003
2	Hypercholesterolemia 08/2005 - 09/2002
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2021
1	Reperfusion Injury 12/2021
1	Infarction (Infarctions) 12/2021
1	Hypertension (High Blood Pressure) 10/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Progeria (Hutchinson Gilford Syndrome) 05/2018
1	Premature Aging 05/2018
1	Vascular Calcification 05/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Hyperphosphatemia 01/2018
1	Hypertrophy 01/2017
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2016
1	Infections 01/2016
1	Pathologic Processes 09/2015

Drug/Important Bio-Agent (IBA)

9	Messenger RNA (mRNA)IBA 01/2019 - 11/2004
7	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 12/2021 - 07/2008
6	Proteins (Proteins, Gene)FDA Link 05/2018 - 03/2003
5	LipidsIBA 07/2022 - 01/2008
5	Transcription Factors (Transcription Factor)IBA 10/2021 - 01/2003
5	Apolipoproteins E (ApoE)IBA 10/2020 - 12/2013
5	EnzymesIBA 01/2020 - 01/2007
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2021 - 09/2016
4	CytokinesIBA 01/2021 - 09/2011
4	CollagenIBA 10/2020 - 01/2013
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2007
3	Angiotensin IIIBA 01/2021 - 01/2017
3	oxidized low density lipoproteinIBA 01/2019 - 09/2002
3	Thrombin FDA Link 06/2012 - 02/2008
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2009 - 03/2006
2	Superoxides (Superoxide)IBA 12/2021 - 03/2016
2	ElementsIBA 04/2021 - 02/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2021 - 01/2021
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2018
2	AminopropionitrileIBA 03/2016 - 06/2015
2	Histone Deacetylase InhibitorsIBA 01/2016 - 01/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 01/2016
2	ProstaglandinsIBA 12/2013 - 04/2011
2	bemiparinIBA 05/2010 - 07/2008
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2009 - 02/2006
2	Simvastatin (Zocor)FDA LinkGeneric 08/2009 - 08/2005
2	C-Reactive ProteinIBA 02/2008 - 06/2007
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 02/2008 - 06/2007
2	Hemostatics (Antihemorrhagics)IBA 02/2008 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 02/2006 - 01/2003
2	Antisense OligonucleotidesIBA 02/2006 - 01/2003
1	CarbohydratesIBA 07/2022
1	RolipramIBA 03/2021
1	ChemokinesIBA 01/2021
1	Member 3 Group A Nuclear Receptor Subfamily 4IBA 01/2021
1	ElastinIBA 01/2021
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2021
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2019
1	AntioxidantsIBA 11/2019
1	mitoquinoneIBA 11/2019
1	NucleotidesIBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	prelamin AIBA 05/2018
1	acetyl-LDLIBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2018
1	Matrix Metalloproteinase 17IBA 01/2018
1	CholesterolIBA 11/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2016
1	Connective Tissue Growth FactorIBA 03/2016
1	LeptinIBA 03/2016
1	NestinIBA 01/2016
1	entinostat (MS 275)IBA 01/2016
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2015
1	MicroRNAs (MicroRNA)IBA 09/2015
1	Oxidoreductases (Dehydrogenase)IBA 06/2015

Therapy/Procedure

3	Therapeutics 01/2021 - 06/2007
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2016
2	Renal Dialysis (Hemodialysis) 05/2010 - 07/2008